FDA
The new article provides guidance on accidental radiation occurrences (AROs), record-keeping responsibilities, and managing defects in diagnostic x-ray systems.
FDA
The new article further describes the regulatory approach to be applied with respect to X-ray products, explaining the key concepts and ideas.
FDA
The article highlights the key points related to the radiation control legal framework.
FDA
The new article focuses on fluoroscopic X-ray systems and the regulatory requirements established, particularly changes effective on June 10, 2006, providing guidance on compliance, system modifications, and operational features.
DRAP
The article provides a general overview of the pharmacovigilance system, highlighting the key points and aspects.
Gartner® Market Guide for Life Science Regulatory Information Management Solutions
Download NowGartner® Market Guide for Regulatory Intelligence Solutions
Download Now
